-
[FDA] FDA Clears First Brain Stimulation Device to Help Smokers Quit
The US Food and Drug Administration (FDA) has granted marketing approval for the BrainsWay deep transcranial magnetic stimulation (TMS) system to help adult smokers kick tobacco.read more -
[MagVenture] FDA clears MagVenture TMS Therapy for OCD
The FDA has cleared MagVenture TMS Therapy® for adjunct treatment of Obsessive-Compulsive Disorder (OCD) in adult patients*.read more -
[EurekAlert!] Dr. Colleen Hanlon Discusses TMS
Dr. Colleen Hanlon discusses Transcranial Magnetic Stimulation and her most recent paper in Translational Psychiatry.read more -
[Harvard Medical School] Transcranial magnetic stimulation (TMS): Hope for stubborn depression
Approximately 50% to 60% of people with depression who have tried and failed to receive benefit from medications experience a clinically meaningful response with TMS.read more -
Chronic Illness and Mental Health: Recognizing and Treating Depression
People with other chronic medical conditions have a higher risk of depression. Seek help if this is you.read more -
Treating chronic depression using magnetic stimulation
Almost a third of people diagnosed with clinical depression do not respond to medication or talk therapy.read more -
Magnetic Pulses to Brain Bring Relief for Tinnitus Patients
“For some study participants, this was the first time in years that they experienced any relief in symptoms,”read more -
BrainsWay’s Deep Transcranial Magnetic Stimulation (TMS)
FDA-Cleared, non-invasive, well-tolerated outpatient treatment clinically proven to improve the symptoms of Major Depression, even in treatment-resistant patients.read more -
TMS Can Help Patients With Depression
Major depressive disorder is a debilitating disease believed to affect more than 300 million people worldwide. Researchers estimate that by the year 2020, depression will be the second leading cause of disability worldwide (1, 2).read more -
Duke University: Details for the Brain Stimulation Center
The Brain Stimulation Service Center (BSSC) is a core research facility in the Duke University School of Medicine that provides equipment and technical services to carry out noninvasive neuromodulatory research studies using Transcranial Magnetic Stimulatread more